Evidence and interdisciplinary consense-based German guidelines: Diagnosis and surveillance of melanoma

Melanoma Research

Volumn 17, Issue 6, 2007, Pages 393-399

  Garbe, Claus ^a   Hauschild, Axel ^b   Volkenandt, Matthias ^c   Schadendorf, Dirk ^d   Stolz, Wilhelm ⁱ   Reinhold, Uwe ^j   Kortmann, Rolf Dieter ^k   Kettelhack, Christoph ⁿ   Frerich, Bernhard ^k   Keilholz, Ulrich ^l   Dummer, Reinhard ^d   Sebastian, Günther ^e   Tilgen, Wolfgang ^f   Schuler, Gerold ^g   Mackensen, Andreas ^m   Kaufmann, Roland ^h  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c University Department of Neurology   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁱ University Medical Center ^*  (Germany)

^j UNIVERSITY HOSPITAL BONN   (Germany)

^k UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m University Department of Medical Oncology   (Germany)

ⁿ Departments of Surgery   (Switzerland)

more..

Author keywords

A B C D rule; Dermoscopy; Melanoma diagnosis; Surveillance; Tumor node metastasis classification

Indexed keywords

LACTATE DEHYDROGENASE; PROTEIN S100B; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; ENZYME BLOOD LEVEL; EPILUMINESCENCE MICROSCOPY; FOLLOW UP; GERMANY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INTERDISCIPLINARY RESEARCH; MELANOMA; MICROMETASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SKIN ULCER; TUMOR VOLUME;

EID: 36048961068     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282f05039     Document Type: Article

References (38)

1. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19-20:219-240.
2. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001; 14:280-290.
3. Garbe C. Epidemiology of skin cancer [in German]. In: Garbe C, Dummer R, Kaufmann R, Tilgen W, editors. Dermatologische Onkologie. Berlin, Heidelberg, New York, Tokyo: Springer; 1997. pp. 40-56.
4. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102:695-699.
5. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-468.
6. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989; 2:487-490.
7. Greene MH, Clark W, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 1985; 102:458-465.
8. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1812 kindergarten children. Cancer 2003; 97:628-638.
9. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995; 75:2484-2491.
10. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-2634.
11. Garbe C, Ellwanger U, Tronnier M, Brocker EB, Orfanos CE. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry. Cancer 2002; 94:2305-2307.
12. Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer 1995; 75:2492-2498.
13. Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000; 88:1484-1491.
14. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
15. Garbe C. Initial diagnostics, staging diagnostics and estimation of prognosis in primary melanoma [in German]. Onkologe 1996; 2: 441-448.
16. Kaufmann R, Proebstle T, Sterry W. Malignant melanoma [in German]. In: Zeller WJ, zur Hausen H, editors. Onkologie. Erlangen: Ecomed; 1995.
17. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159-165.
18. Pehamberger H, Binder M, Steiner A, Wolff K. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993; 100:356S-362S.
19. Soyer H, Argenziano G, Chimenti S, Menzies SW, Pehamberger H, Rabinowitz HS, et al. Dermoscopy of pigmented skin lesions. An atlas based on the Consensus Net Meeting on Dermoscopy 2000. Milan: Edra; 2001.
20. Stolz W, Riemann A, Cognetta AB, Pillet L, Abmayr W, Hölzel D, et al. ABCD rule of dermoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol 1994; 4:521-527
21. Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55-62.
22. Argenziano G, Fabbrocini G, Carli P, de Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134: 1563-1570.
23. Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 2000; 43:467-476.
24. Krahn G, Gottlober P, Sander C, Peter RU. Dermatoscopy and high frequency sonography: two useful non-invasive methods to increase preoperative diagnostic accuracy in pigmented skin lesions. Pigment Cell Res 1998; 11:151-154.
25. Serrone L, Solivetti FM, Thorel MF, Eibenschutz L, Donati P, Catricala C. High frequency ultrasound in the preoperative staging of primary melanoma: a statistical analysis. Melanoma Res 2002; 12:287-290.
26. Orfanos CE, Jung EG, Rassner G, Wolff HH, Garbe C. Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94 [in German]. Hautarzt 1994; 45:285-291.
27. Eggermont AM. Monitoring of patients with stage I melanoma after excision of the primary tumor [in French]. Ann Dermatol Venereol 1995; 122: 292-297.
28. Eggermont AM. Monitoring of patients with stage I melanoma after excision of the primary tumor: simple and cost efficient [in German]. Der Onkologe 1996; 2:480.
29. Kleeberg UR. Wishful thinking, unicentric empiricism and the everyday world of the medical melanomologist. Melanoma Res 1997; 7 (Suppl 2): S143-S149.
30. Ardizzoni A, Grimaldi A, Repetto L, Bruzzone M, Sertoli MR, Rosso R. Stage I-II melanoma: the value of metastatic work-up. Oncology 1987; 44:87-89.
31. Basseres N, Grob JJ, Richard MA, Thirion X, Zarour H, Noe C, et al. Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France. Dermatology 1995; 191:199-120.
32. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 1995; 274:1703-1705.
33. Huang CL, Provost N, Marghoob AA, Kopf AW, Levin L, Bart RS. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma. J Am Acad Dermatol 1998; 39:451-463.
34. Iscoe N, Kersey P, Gapski J, Osoba D, From L, DeBoer G, Quirt I. Predictive value of staging investigations in patients with clinical stage I malignant melanoma. Plast Reconstr Surg 1987; 80:233-239.
35. Terhune MH, Swanson N, Johnson TM. Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol 1998; 134:569-572.
36. Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients: monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002; 87: 151-157.
37. Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21:520-529.
38. Garbe C, Schadendorf D. Malignant melanoma: new data and concepts of surveillance [in German]. Dtsch Arztebl 2003; 100.A: 1804-1808.